HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic lupus erythematosus with ADAMTS13 inhibitor-negative thrombotic microangiopathy treated with combination of mycophenolate mofetil, plasma exchange and steroid.

AuthorsM Okubo, H Shoda, E Bannai, K Kubo, H Kanda, K Fujio, K Yamamoto
JournalLupus (Lupus) Vol. 26 Issue 3 Pg. 334-336 (Mar 2017) ISSN: 1477-0962 [Electronic] England
PMID27416846 (Publication Type: Case Reports, Letter)
Chemical References
  • Steroids
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • Mycophenolic Acid
Topics
  • ADAMTS13 Protein (genetics)
  • Adult
  • Combined Modality Therapy
  • Female
  • Humans
  • Kidney (pathology)
  • Lupus Erythematosus, Systemic (complications, drug therapy, pathology)
  • Male
  • Middle Aged
  • Mycophenolic Acid (administration & dosage)
  • Plasma Exchange (methods)
  • Steroids (administration & dosage)
  • Thrombotic Microangiopathies (drug therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: